Inside the Third Plenary: Balancing Speed, Scientific Rigor and Patient-Centered Use of Surrogate Endpoints
2025/05/17 | The Evidence Base
ISPOR 2025 Digital Conference Pass
2025/05/17 | ISPOR
ISPOR 2025 Daily Round-Ups: Day 3
2025/05/17 | The Evidence Base
Inside the Second Plenary: The Innovation Driving the Future of HTA
2025/05/15 | The Evidence Base
ISPOR 2025 Daily Round-Ups: Day 2
2025/05/15 | The Evidence Base
Inside the First Plenary: Unintended Effects of Drug Price Regulation on Innovation
2025/05/15 | The Evidence Base
ISPOR 2025 Daily Round-Ups: Day 1
2025/05/15 | The Evidence Base
Unlocking Affordability and Access with HEOR
2025/05/12 | Value & Outcomes Spotlight
Climate Change Is Silently Eroding Workforce Health and Productivity
2025/05/12 | Health Affairs Forefront
ISPOR Publishes Insights From Its First Global HTA Roundtable
2025/05/12 | ISPOR
Streamlining Development and Assessment of Biosimilar Medicines
2025/05/11 | European Medicines Agency
New Position Statement Aims to Guide the Use of AI Methods in Health Technology Assessment
2025/05/11 | Canada’s Drug Agency
Increases in Vaccine-Preventable Disease Outbreaks Threaten Years of Progress, Warn WHO, UNICEF, Gavi
2025/05/11 | World Health Organization
Generating Evidence to Support the Role of AI in Diabetic Eye Screening
2025/05/11 | The Lancet Digital Health
FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
2025/05/10 | US Food and Drug Administration
NORD CEO Statement on the Termination of the Advisory Committee on Heritable Disorders in Newborns and Children
2025/05/10 | National Organization for Rare Disorders
Newborn Screening at Risk: Implications of Disbanding the Advisory Committee On Heritable Disorders In Newborns and Children
2025/05/10 | Health Affairs
New Pan-Canadian Recommendations for Newborn Screening in Canada
2025/05/10 | Canada’s Drug Agency
WHO Launches First-Ever Guidelines on Meningitis Diagnosis, Treatment, and Care
2025/05/10 | World Health Organization
Effectiveness of Influenza Vaccination in Preventing Severe COPD Exacerbations and Pneumonia Before, During, and After the COVID-19 Pandemic
2025/05/09 | The Lancet Regional Health Europe
- 1 (current)
- 2
- 3
- 4
- 5
Subscribe to the HEOR News Desk
SubscribeAlready have an ISPOR Profile? Click here to manage your subscriptions.